A Study of a Surgical Guide for Dental Implantology
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03854162 |
|
Recruitment Status :
Completed
First Posted : February 26, 2019
Last Update Posted : March 7, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Dental Implantation, Endosseous Dental Implants Minimally Invasive Surgical Procedures Surgery, Oral Surgery, Computer-Assisted | Device: SMART Guide | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 119 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | The Accuracy of Partially or Fully Guided Dental Implantation Performed With Dental Implantological Surgical Guide as Compared to Freehand Dental Implantation |
| Actual Study Start Date : | August 17, 2018 |
| Actual Primary Completion Date : | November 30, 2018 |
| Actual Study Completion Date : | February 28, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: FREEHAND
For these cases, the regular protocol of the study site is observed. The operator has the plan at their disposal projected on a screen in the operating theater. The preparation of the bony bed and the insertion of the implant are performed freehand, without any guidance. The positions and directions are determined with the naked eye, observing the plan projected on the screen. At the end of the operation, the operation site is checked, hemostasis is provided, and the operator records the operation in the source documentation. 2±1 days later, a postoperative CT scan is taken. A follow-up visit is due 14±2 weeks later, after the osseointegration period.
|
Device: SMART Guide
The device manufactured according to a digital plan based on patient anatomy. Guiding sleeves are used, through which bone drills are applied. These sleeves sit in a plastic template that is a negative of the patient's dentition, so that the guide is properly stabilized during the operation. The position of the sleeves is calculated from the surgical plan in a way that they guide the drills in the planned position.The material of the template is medical plastic, the sleeves are made of medical steel.The device is applied by the dentist during the implant surgery. The template is placed on the remaining dentition of the patient and stabilized this way. By this, the sleeves are also stabilized in their planned position. Access through the soft tissue can be prepared through the given sleeve with a circular trephine, but the system also supports flap surgery. As access has been established, the dentist performs the surgical protocol as planned. |
|
Active Comparator: PILOT
The SMART Guide surgical template is applied only in the initial phase of the operation. After having prepared soft tissue access, the template is placed, and only one drilling is performed through its sleeve, with the so-called pilot drill. The resulting borehole serves as directional guidance for the drills applied later in the process. Further drilling and implant insertion are both performed freehand. At the end of the operation, the operation site is checked, hemostasis is provided, and the operator records the operation in the source documentation. 2±1 days later, a postoperative CT scan is taken. A follow-up visit is due 14±2 weeks later, after the osseointegration period.
|
Device: SMART Guide
The device manufactured according to a digital plan based on patient anatomy. Guiding sleeves are used, through which bone drills are applied. These sleeves sit in a plastic template that is a negative of the patient's dentition, so that the guide is properly stabilized during the operation. The position of the sleeves is calculated from the surgical plan in a way that they guide the drills in the planned position.The material of the template is medical plastic, the sleeves are made of medical steel.The device is applied by the dentist during the implant surgery. The template is placed on the remaining dentition of the patient and stabilized this way. By this, the sleeves are also stabilized in their planned position. Access through the soft tissue can be prepared through the given sleeve with a circular trephine, but the system also supports flap surgery. As access has been established, the dentist performs the surgical protocol as planned. |
|
Active Comparator: PARTIAL GUIDE
The only non-guided step is implant insertion, that is, all drilling happens through the SMART Guide surgical template. After having prepared soft tissue access, the guide is placed, and all drillings are performed through it, according to the surgical protocol. Here the depth of the bony bed is also determined, as the sleeve does not allow the drill to move any deeper than planned. At the end of the operation, the operation site is checked, hemostasis is provided, and the operator records the operation in the source documentation. 2±1 days later, a postoperative CT scan is taken. A follow-up visit is due 14±2 weeks later, after the osseointegration period.
|
Device: SMART Guide
The device manufactured according to a digital plan based on patient anatomy. Guiding sleeves are used, through which bone drills are applied. These sleeves sit in a plastic template that is a negative of the patient's dentition, so that the guide is properly stabilized during the operation. The position of the sleeves is calculated from the surgical plan in a way that they guide the drills in the planned position.The material of the template is medical plastic, the sleeves are made of medical steel.The device is applied by the dentist during the implant surgery. The template is placed on the remaining dentition of the patient and stabilized this way. By this, the sleeves are also stabilized in their planned position. Access through the soft tissue can be prepared through the given sleeve with a circular trephine, but the system also supports flap surgery. As access has been established, the dentist performs the surgical protocol as planned. |
|
Active Comparator: FULL GUIDE
The SMART Guide surgical template is used for all steps of the operation, including the insertion of the implant. Apart from this, the procedure is exactly the same as described under "partial guide".
|
Device: SMART Guide
The device manufactured according to a digital plan based on patient anatomy. Guiding sleeves are used, through which bone drills are applied. These sleeves sit in a plastic template that is a negative of the patient's dentition, so that the guide is properly stabilized during the operation. The position of the sleeves is calculated from the surgical plan in a way that they guide the drills in the planned position.The material of the template is medical plastic, the sleeves are made of medical steel.The device is applied by the dentist during the implant surgery. The template is placed on the remaining dentition of the patient and stabilized this way. By this, the sleeves are also stabilized in their planned position. Access through the soft tissue can be prepared through the given sleeve with a circular trephine, but the system also supports flap surgery. As access has been established, the dentist performs the surgical protocol as planned. |
- Angle deviation [ Time Frame: 3 months ]The angle closed by the principal axis of the digitally implant as planned and the actual implant as placed expressed in degrees.
- Apical deviation [ Time Frame: 3 months ]The deviation of the apical point of the placed implant from the apical point as planned in the three dimensional space, expressed in millimeters.
- Hex deviation (also known as coronal deviation) [ Time Frame: 3 months ]The angle closed by the principal axis of the digitally implant as planned and the actual implant as placed expressed in degrees (to one decimal).
- Volume overlap [ Time Frame: 3 months ]the overlap between the planned model implant and the placed implant as digitally Reconstructed from a postoperative cone-beam CT scan, expressed as a percentage.
- Adverse events [ Time Frame: 6 months ]The occurrence of adverse events, expressed as the number and seriousness of adverse events.
- Volunteer satisfaction [ Time Frame: 6 months ]The subjective satisfaction of volunteers as assessed by the Oral Health Impact Profile questionnaire, and a custom volunteer satisfaction questionnaire. Questionnaires administered three times during study period.
- Dentist (operator) satisfaction [ Time Frame: 3 months ]The subjective satisfaction of the operating dentist with the surgery as an experience, assessed by a custom questionnaire. Questionnaire administered after each surgery.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Male and female volunteers between 18 and 75 years of age
- Partial edentulousness of the mandible or maxilla
- Clinical situation fit for implantation as judged by the examining physician or principal investigator (satisfactory soft and hard tissue conditions and occlusion)
- The volunteer communicates well with the examiner and compliance can be expected.
Informed consent.
Exclusion Criteria:
- Pregnancy or lactation. Pregnancy is defined as the period beginning with conception and ending with birth.
-
Women in their childbearing age; by definition, any woman who - unless she uses effective contraception - can get pregnant in a physiological way. Eligibility for this study presupposes that the female subject will use effective contraception until 4 weeks after the end of her participation in the study. Effective contraception is defined as any of the following:
- Barrier method: condom or diaphragm or cervical cap with spermicide. Note that spermicide in itself is not a barrier!
- Full abstinence (if this is acceptable for the subject). Periodic abstinence, like the calendar- and temperature-based methods and interrupted intercourse are not acceptable.
- Female sterilization: bilateral oophorectomy w/wo histerectomy or tubal ligation at least six weeks before participation in the study.
- Sterilization of the male partner: vasectomy (no spermia in the ejaculate). The only partner of the participating female can be a male who has undergone vasectomy.
- Hormonal contraception (oral, injection, or implanted); intrauterine device (IUD) or intrauterine system (IUS).
- Any disease (including but not exclusively the diseases of metabolism, hematological diseases, diseases of the liver, the kidneys, the lungs, the nervous system, the endocrine organs, the heart and the intestines and infectious diseases) that, in the principal investigator's opinion, has a significant effect on the subject's general health and/or means an unacceptable risk factor for the person to receive implant treatment.
- Known HIV, Hepatitis B or Hepatitis C infection.
- Any internal or psychiatric disease that, in the opinion of the principal investigator, would risk compliance with the instructions or participation until the end of the study.
- Participation in an experimental study or trial within four weeks before the randomization, or within five times the half-life of the experimental agent (whichever is longer)
- Known allergy to any component of the implant or the implant guide
- Limited mouth opening, which, in the examiner's opinion, would risk the success of the intervention
- Increased gag reflex, poor tolerance of intraoral manipulation
- Radiotherapy, irradiation of the mandible or the maxilla (either at the time of screening or in the past)
- INR>2.5
- Immunosuppressed state
- Bisphosphonate treatment (either at the time of screening or in the past)
- Alcohol or drug abuse
- Habitual smoking
- Untreated periodontitis
- Retained root in the planned insertion site
- Local infection
- Lack of dental sanitation
- Poor oral hygiene
- Infection w/wo fever
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03854162
| Hungary | |
| University of Szeged, Department of Oral and Maxillofacial Surgery | |
| Szeged, Hungary, 6725 | |
| Responsible Party: | Szeged University |
| ClinicalTrials.gov Identifier: | NCT03854162 |
| Other Study ID Numbers: |
IMP SMART 002 |
| First Posted: | February 26, 2019 Key Record Dates |
| Last Update Posted: | March 7, 2019 |
| Last Verified: | March 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

